Back to search

Article

Comparative Effectiveness Of Three Bevacizumab Formulations In Iris Neovascularization: A Propensity Score-Matched Equivalence Study With Pupillographıc Validation

2026-06-22

Abstract excerpt

<title>Abstract</title> <p>Purpose This study had two primary objectives: (1) to validate automated pupillography as a reliable quantitative research tool in iris neovascularization (NVI); and (2) to compare the 24-month pupillographic outcomes of three bevacizumab formulations (Altuzan, Zirabev, Mvasi) using equivalence testing in a head-to-head design. Methods Among 78 treatment-naive NVI patients, 1:1:1 prop...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
527e320b-9622-535a-bbdf-c4f445442f47
DOI
10.21203/rs.3.rs-9869549/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparative Effectiveness Of Three Bevacizumab Formulations In Iris Neovascularization: A Propensity Score-Matched Equivalence Study With Pupillographıc ValidationDOI 10.21203/rs.3.rs-9869549/v1
Select a neighboring publication to make it the new centre.